Adcock Ingram aborts bid to acquire Cipla Medpro
This article was originally published in Scrip
Executive Summary
Adcock Ingram has aborted its bid to acquire Cipla Medpro South Africa (CMSA) in view of the lack of response from the CMSA board and concerns about what Cipla India might do – the latter has a commercial relationship with CMSA.